106 related articles for article (PubMed ID: 28539426)
1. Conservatism and the cancer drugs fund.
Hopkinson NS
BMJ; 2017 May; 357():j2451. PubMed ID: 28539426
[No Abstract] [Full Text] [Related]
2. Reforming the cancer drug fund.
Buxton M; Longworth L; Raftery J; Sculpher M; Towse A
BMJ; 2014 Nov; 349():g7276. PubMed ID: 25432928
[No Abstract] [Full Text] [Related]
3. Challenges for the new Cancer Drugs Fund.
Littlejohns P; Weale A; Kieslich K; Wilson J; Rumbold B; Max C; Rid A
Lancet Oncol; 2016 Apr; 17(4):416-418. PubMed ID: 26948924
[No Abstract] [Full Text] [Related]
4. MPs find no evidence that Cancer Drugs Fund was spent wisely.
Hawkes N
BMJ; 2016 Feb; 352():i755. PubMed ID: 26850036
[No Abstract] [Full Text] [Related]
5. Investment fund established to combat cancer drug 'development gap'.
Hemsley A
Future Med Chem; 2012 May; 4(8):948. PubMed ID: 22826901
[No Abstract] [Full Text] [Related]
6. Calling time on the Cancer Drugs Fund? Funding the NHS in the age of austerity.
Emmerich N
Br J Hosp Med (Lond); 2015 Apr; 76(4):186-7. PubMed ID: 25853345
[No Abstract] [Full Text] [Related]
7. NICE and the Cancer Drugs Fund--2020 vision?
Drug Ther Bull; 2016 Apr; 54(4):37. PubMed ID: 27056193
[No Abstract] [Full Text] [Related]
8. Cancer Drugs Fund failed to collect patient outcomes.
Baker H
Lancet Oncol; 2015 Nov; 16(15):e529. PubMed ID: 26411398
[No Abstract] [Full Text] [Related]
9. Cost of hospital prescribing rose 15% in a year owing to new rheumatoid arthritis and cancer drugs.
Hawkes N
BMJ; 2014 Nov; 349():g6867. PubMed ID: 25404423
[No Abstract] [Full Text] [Related]
10. New "managed access" process for Cancer Drugs Fund to go ahead, NHS England confirms.
Mayor S
BMJ; 2016 Feb; 352():i1208. PubMed ID: 26926879
[No Abstract] [Full Text] [Related]
11. At last, NICE to take over the Cancer Drugs Fund.
Timmins N
BMJ; 2016 Mar; 352():i1324. PubMed ID: 26951838
[No Abstract] [Full Text] [Related]
12. The economics of the NHS cancer drugs fund.
Maynard A; Bloor K
Appl Health Econ Health Policy; 2011 May; 9(3):137-8. PubMed ID: 21506619
[No Abstract] [Full Text] [Related]
13. Which way now for the Cancer Drugs Fund?
Jack A
BMJ; 2014 Sep; 349():g5524. PubMed ID: 25204283
[No Abstract] [Full Text] [Related]
14. Where next for the Cancer Drugs Fund?
Joffe J
Br J Hosp Med (Lond); 2013 Mar; 74(3):156-9. PubMed ID: 23665785
[No Abstract] [Full Text] [Related]
15. UK Cancer Drugs Fund to reassess 42 agents.
Cagney H
Lancet Oncol; 2015 Jan; 16(1):e8. PubMed ID: 25638560
[No Abstract] [Full Text] [Related]
16. Putting a price on hope.
Goozner M
J Natl Cancer Inst; 2012 Sep; 104(17):1274-5. PubMed ID: 22914787
[No Abstract] [Full Text] [Related]
17. NHS will not pay for drugs that offer little clinical benefit, says cancer fund boss.
Kmietowicz Z
BMJ; 2015 Jan; 350():h125. PubMed ID: 25569117
[No Abstract] [Full Text] [Related]
18. Is it time for a dedicated tax to fund the NHS?
Layard R; Appleby J
BMJ; 2017 Feb; 356():j471. PubMed ID: 28179269
[No Abstract] [Full Text] [Related]
19. New 50 million pound cancer fund already intellectually bankrupt.
Lancet; 2010 Aug; 376(9739):389. PubMed ID: 20692511
[No Abstract] [Full Text] [Related]
20. Unfunded promises as the UK health debate takes centre stage.
Lancet Oncol; 2010 May; 11(5):401. PubMed ID: 20409754
[No Abstract] [Full Text] [Related]
[Next] [New Search]
